Impedimed (Australia) Buy Hold or Sell Recommendation
| IPD Stock | 0.05 0 1.92% |
Assuming the 90 days trading horizon and your complete indifference towards market risk, our recommendation regarding Impedimed is 'Buy'. A buy or sell recommendation provided by Macroaxis is an automated directive regarding whether to purchase or sell Impedimed given historical horizon and risk tolerance towards Impedimed. When Macroaxis issues a 'buy' or 'sell' recommendation for Impedimed, the advice is generated through an automated system that utilizes algorithms and statistical models.
Check out Impedimed Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as Impedimed and provide practical buy, sell, or hold advice based on investors' constraints. Impedimed. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
Impedimed |
Execute Impedimed Buy or Sell Advice
The Impedimed recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on Impedimed. Macroaxis does not own or have any residual interests in Impedimed or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute Impedimed's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Buy
Market Performance | Weak | Details | |
Volatility | Out of control | Details | |
Hype Condition | Over hyped | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | Below Average | Details | |
Economic Sensitivity | Follows the market closely | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
Impedimed Trading Alerts and Improvement Suggestions
| Impedimed has some characteristics of a very speculative penny stock | |
| Impedimed had very high historical volatility over the last 90 days | |
| The company reported the revenue of 10.32 M. Net Loss for the year was (19.79 M) with profit before overhead, payroll, taxes, and interest of 9.8 M. | |
| Impedimed has accumulated about 13.55 M in cash with (17.79 M) of positive cash flow from operations. | |
| Latest headline from news.google.com: ImpediMed Limited Focuses on Commercial Growth Strategy - TipRanks |
Impedimed Returns Distribution Density
The distribution of Impedimed's historical returns is an attempt to chart the uncertainty of Impedimed's future price movements. The chart of the probability distribution of Impedimed daily returns describes the distribution of returns around its average expected value. We use Impedimed price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of Impedimed returns is essential to provide solid investment advice for Impedimed.
| Mean Return | 0.04 | Value At Risk | -5.45 | Potential Upside | 6.00 | Standard Deviation | 4.58 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of Impedimed historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
Impedimed Cash Flow Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Capital Expenditures | 2.2M | 2.5M | 5.2M | 6.0M | 3.1M | 3.3M | |
| Change To Inventory | 257K | 492K | (554K) | 115K | 51K | 53.6K | |
| End Period Cash Flow | 19.7M | 19.7M | 40.7M | 45.7M | 24.6M | 27.4M | |
| Change In Cash | 8.3M | 18K | 21.0M | 5.0M | (21.1M) | (20.0M) | |
| Free Cash Flow | (21.4M) | (15.7M) | (20.9M) | (24.1M) | (20.9M) | (21.9M) | |
| Depreciation | 464K | 354K | 1.2M | 678K | 2.3M | 2.4M | |
| Other Non Cash Items | 1.7M | 7.1M | 3.0M | 1.8M | 21K | 20.0K | |
| Net Income | (21.4M) | (20.7M) | (19.9M) | (20.5M) | (19.8M) | (20.8M) | |
| Change To Netincome | 2.6M | 3.0M | 2.9M | 305K | 274.5K | 260.8K | |
| Investments | (2.2M) | (2.5M) | (5.2M) | (6.0M) | (3.1M) | (3.3M) |
Impedimed Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to Impedimed or Health Care Equipment & Supplies sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that Impedimed's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a Impedimed stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | -0.06 | |
β | Beta against Dow Jones | 0.74 | |
σ | Overall volatility | 4.56 | |
Ir | Information ratio | -0.02 |
Impedimed Volatility Alert
Impedimed shows above-average downside volatility for the selected time horizon. Impedimed is a penny stock. Although Impedimed may be in fact a good investment, many penny stocks are subject to artificial price hype. Make sure you completely understand the upside potential and downside risk of investing in Impedimed. We encourage investors to look for signals such as message board hypes, claims of breakthroughs, email spams, sudden volume upswings, and other similar hype indicators. We also encourage traders to check biographies and work history of company officers before investing in instruments with high volatility. You can indeed make money on Impedimed instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of artificial hype usually unable to maintain their increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.Impedimed Fundamentals Vs Peers
Comparing Impedimed's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze Impedimed's direct or indirect competition across all of the common fundamentals between Impedimed and the related equities. This way, we can detect undervalued stocks with similar characteristics as Impedimed or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of Impedimed's fundamental indicators could also be used in its relative valuation, which is a method of valuing Impedimed by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare Impedimed to competition |
| Fundamentals | Impedimed | Peer Average |
| Return On Equity | -0.39 | -0.31 |
| Return On Asset | -0.26 | -0.14 |
| Profit Margin | (1.92) % | (1.27) % |
| Operating Margin | (2.01) % | (5.51) % |
| Current Valuation | 81.74 M | 16.62 B |
| Shares Outstanding | 2.02 B | 571.82 M |
| Shares Owned By Insiders | 9.07 % | 10.09 % |
| Shares Owned By Institutions | 16.29 % | 39.21 % |
| Price To Book | 2.58 X | 9.51 X |
| Price To Sales | 10.00 X | 11.42 X |
| Revenue | 10.32 M | 9.43 B |
| Gross Profit | 9.8 M | 27.38 B |
| EBITDA | (22.05 M) | 3.9 B |
| Net Income | (19.79 M) | 570.98 M |
| Cash And Equivalents | 13.55 M | 2.7 B |
| Total Debt | 1.14 M | 5.32 B |
| Book Value Per Share | 0.02 X | 1.93 K |
| Cash Flow From Operations | (17.79 M) | 971.22 M |
| Earnings Per Share | (0.01) X | 3.12 X |
| Target Price | 0.15 | |
| Number Of Employees | 83 | 18.84 K |
| Beta | 2.87 | -0.15 |
| Market Capitalization | 103.2 M | 19.03 B |
| Total Asset | 46.99 M | 29.47 B |
| Retained Earnings | (330.95 M) | 9.33 B |
| Working Capital | 24.8 M | 1.48 B |
| Net Asset | 46.99 M |
Impedimed Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as Impedimed . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
About Impedimed Buy or Sell Advice
When is the right time to buy or sell Impedimed? Buying financial instruments such as Impedimed Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having Impedimed in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Adviser Favorites Thematic Idea Now
Adviser Favorites
Financial advisors frequently recommend that individuals diversify their investment portfolios with a mix of different types of stocks. These can include blue-chip stocks, growth stocks, and dividend stocks. The Adviser Favorites theme has 17 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Adviser Favorites Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Impedimed Stock Analysis
When running Impedimed's price analysis, check to measure Impedimed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Impedimed is operating at the current time. Most of Impedimed's value examination focuses on studying past and present price action to predict the probability of Impedimed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Impedimed's price. Additionally, you may evaluate how the addition of Impedimed to your portfolios can decrease your overall portfolio volatility.